UNSPSC 51372324: Ocfentanil hydrochloride

This classification denotes an opioid receptor agonist with the molecular formula C22H27FN2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z8T88FVW9V, chemically known as acetamide, n-(2-fluorophenyl)-2-methoxy-n-(1-(2-phenylethyl)-4-piperidinyl)- but more generally known as ocfentanil hydrochloride, which bears US NIH Compound Identifier 60575. Most nations, for tariff and trade purposes, schedule ocfentanil hydrochloride under HS 29333999 and SITC 51574.

As of Q4 2014, OCFENTANIL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Ocfentanil hydrochloride bears US NLM identifiers UMLS ID C2698645 and NCI Concept Code C76850. SMILES: COCC(=O)N(C1CCCCC1F)C2CCN(CC2)CCC3CCCCC3.CL.

UNSPSC 51372324 Ocfentanil hydrochloride, a Commodity code, reflects state and local procurement of pharmaceutical products and drug-related supplies for public health and emergency response. The recent activity under this code shows procurement officers buying naloxone and drug deactivation systems rather than the pharmaceutical compound itself — a mismatch that signals minimal direct purchasing of ocfentanil hydrochloride at the state and local level. County health departments and emergency management divisions are the primary buying entities, procuring these items to support opioid overdose response and harm-reduction initiatives as part of community health programming.

Seminole County, Florida posted the only recent opportunity in the available record: IFB60459723LAS, an invitation for bid issued June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The bid response deadline was July 26, 2023, at 2:00 pm. The contract carried a two-year initial term with one-year renewal option, fixed-fee pricing, and compliance requirements including drug-free workplace certification, E-Verify, workers' compensation, commercial general liability, and professional liability insurance. Potential FEMA funding introduced additional federal compliance obligations. The code shows limited recent state and local procurement activity; most buying appears concentrated in Florida counties engaged in opioid response and public health harm reduction rather than broad pharmaceutical procurement.